ANGPT2 and neoplasm: In contrast to its broad expression in the vasculature of human tumors, Ang-2 shows limited postnatal expression in normal tissue (e.g. at sites of vascular remodeling like ovary, placenta, uterus) making it a tumor specific target for anti-angiogenic therapies.